[ad_1]
Investors Observer gives Syndax Pharmaceuticals Inc (SNDX) an analyst rating ranking of 60, which means SNDX is ranked higher by analysts than 60% of the stocks. The average price target for SNDX is $ 27.75 and the analyst rates the stock as a strong buy.
Why are analyst ratings important?
You can learn a lot about a business by looking at its financial statements and comparing them to other businesses. Analysts who cover an industry in depth, however, can add even more to your research. They usually follow a particular sector or industry very closely. They also pay attention and ask questions on income conference calls and other events where they might learn information that shows up in the numbers.
Investors Observer takes the average score of these analysts, then the percentile ranks these averages. This allows you to compare stocks much more accurately than just seeing the typical five-level rating system used on most Wall Street.
What is happening with the shares of Syndax Pharmaceuticals Inc today?
Syndax Pharmaceuticals Inc (SNDX) stock is 2.02% higher while the S&P 500 fell -0.66% at 11:37 a.m. on Friday, September 17. SNDX gained $ 0.39 from the previous closing price of $ 19.31 on volume of 273,686 shares. Over the past year, the S&P 500 has gained 32.39% while the SNDX has gained 15.47%. SNDX has lost $ -1.89 per share over the past 12 months. Click here for the full Syndax Pharmaceuticals Inc. share report.
[ad_2]
